We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Mindray Displays New Generation Benchtop Cellular Analysis Line

By LabMedica International staff writers
Posted on 31 Jan 2019

Image: The CAL 6000 benchtop cellular analysis line (Photo courtesy of Mindray).

Image: The CAL 6000 benchtop cellular analysis line (Photo courtesy of Mindray).

Mindray (Shenzhen, China) exhibited its new generation benchtop cellular analysis line at MedLab Middle East, an international platform for laboratory management and medicine that brought together more than 700 exhibitors and over 35,000 professionals. MedLab Middle East 2019 took place at the Dubai International Convention and Exhibition Centre, Dubai, UAE from the 4th to the 7th of February.

Among Mindray’s latest innovations displayed at MedLab Middle East 2019 was CAL 6000, a benchtop cellular analysis line that connects two units of BC-6000 or BC-6200 auto hematology analyzers and one unit of SC-120 auto slide maker & stainer. The compact workstation helps save more laboratory space while delivering a fast throughput of up to 220 samples and 120 slides per hour. It provides automated body fluids test results, and is equipped with labXpert data management software for automatic sample validation and analysis.

At MedLab Middle East 2019, Mindray also exhibited the CL-900i chemiluminescence immunoassay analyzer, which has an industry-leading small benchtop footprint, a throughput of up to 180 tests per hour and 15 reagent positions. The CL-900i is a state-of-the-art system that is compact, fast and accurate, offering automation and reliable performance to ensure quality testing results with minimal hands-on time.

Visit expo >

Gold Member

Clinical Chemistry Assay

Sorbitol Dehydrogenase (SDH)

Online QC Software
Acusera 24•7

Multi-Chamber Washer-Disinfector

WD 390

Food Allergy Screening ELISA Kit

Allerquant 14G B ELISA

Latest MEDLAB 2019 News

Channels

Clinical Chemistry

view channel

Mass Spectrometry Detects Tumor Metabolites for Cancer Monitoring

Cancer’s altered metabolism complicates how clinicians detect and monitor tumors, because nutrient use can shift with context and time. Measuring small-molecule metabolites that distinguish malignant from... Read more

Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures

Many patients with type 2 diabetes and chronic kidney disease continue to experience progressive renal decline, yet conventional markers such as albuminuria and estimated glomerular filtration rate (eGFR)... Read more

Saliva-Based Test Detects Biochemical Signs of Sleep Loss

Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more

Image: Representational Models of Regional Aβ and Tau Deposition Across Plasma Stages (Salvadó G, Horie K, Barthélemy NR, et al. JAMA Neurology. May 26, 2026. doi:10.1001/jamaneurol.2026.1405)

Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease

Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more

Molecular Diagnostics

view channel

New Library Normalization and Amplification Tools Support Oncology Sequencing

High-throughput next-generation sequencing (NGS) laboratories continue to grapple with uneven library pooling and amplification artifacts that can degrade variant calling accuracy and increase reruns.... Read more

Image: The method can analyze samples containing about 5% cancer DNA, compared with the 15–20% typically required by current techniques. (Image Credit: iStock)

Statistical Method Improves Detection of Low-Level Cancer DNA in Blood Samples

Blood-based assays are increasingly used to detect and monitor cancer, but many require relatively high fractions of circulating tumor DNA, limiting their utility when disease burden is low.... Read more

Image: Development of an artificial intelligence method to accurately characterize mutations in liquid biopsies (Image Credit: Valsamo Anagnostou/ChatGPT)

AI Tool Improves Accuracy of Cancer Liquid Biopsy for Therapy Selection

Liquid biopsy is increasingly used to guide targeted therapy by detecting tumor-derived mutations in blood, but distinguishing true tumor signals from background noise remains challenging.... Read more

Study Highlights Inherited Breast Cancer Risk Genes in Young Black Women

Early-onset breast cancer remains a significant concern, with some cases presenting as triple-negative disease, one of its most aggressive forms. Black women face disproportionately elevated risks of developing... Read more

Hematology

view channel

Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows

Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more

Image: Direct and indirect antitumoral effects of eosinophil (Marie Gilon et al., Journal of Experimental & Clinical Cancer Research (2026). DOI: 10.1186/s13046-026-03688-5)

Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity

Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read more

Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children

Iron deficiency in school-age children can affect brain development, learning, growth, and physical performance, yet early deficiency may be missed when screening focuses mainly on anemia.... Read more

Image: Graphical abstract (Waclawiczek A, Leppä AM, Renders S, et al. Cell Stem Cell, 2026. doi:10.1016/j.stem.2026.04.012)

Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read more

Immunology

view channel

Aptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection

Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more

Study Points to Autoimmune Pathway Behind Long COVID Symptoms

Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more

Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response

Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more

Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) affects nearly 3 million people in the United States and its prevalence continues to rise. Medications that target tumor necrosis factor (TNF)-alpha are widely used, but... Read more

Microbiology

view channel

TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy

Congenital TORCH infections can be asymptomatic during pregnancy yet cause stillbirth, birth defects, and lifelong disability in infants. Many regions still lack robust surveillance to guide testing and... Read more

New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs

Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more

Automated Blood Culture System Speeds Detection of Bloodstream Infections

Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read more

Image: Graphical Abstract (Microbiome Research Reports: DOI:10.20517/mrr.2025.96)

Gut Microbiome Signatures Help Identify Risk of IBD Progression

Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic relapsing inflammatory disorder of the gastrointestinal tract with highly variable outcomes.... Read more

Pathology

view channel

AI Tool Speeds Brain Tumor Classification from Routine Histology Slides

Accurate classification of brain and spinal cord tumors increasingly depends on molecular profiling alongside histology, but access to such testing remains limited and results can take about two weeks.... Read more

IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy

Deficient DNA mismatch repair is an established predictive biomarker for response to immune checkpoint inhibitors, yet access to standardized assessment has varied across tumor types. Cancer remains the... Read more

Image: Findings demonstrate that AI can help classify meningiomas by extracting molecular and prognostic information from standard H&E slides already used in routine care. (Image Credit: Mikael Häggström, M.D./Wikimedia Commons, CC0 1.0)

AI Pathology Tool Predicts Meningioma Recurrence from Routine Slides

Meningiomas are the most common primary brain tumors in adults, yet their course ranges from indolent to highly recurrent disease. Estimating an individual patient’s recurrence risk often requires advanced... Read more

3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer

Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more

Technology

view channel

AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines

Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more

Agentic AI Platform Supports Genomic Decision-Making in Oncology

Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read more

Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps

Colorectal cancer screening is a longstanding preventive priority, yet participation and follow-up remain uneven across patient groups. Safety‑net primary care settings often face barriers that limit screening... Read more

Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance

Chronic liver disease is common and often progresses silently, increasing the risk of cirrhosis and hepatocellular carcinoma when not detected early. With an estimated 1.5 billion people affected worldwide... Read more

Industry

view channel

Open-Source Consortium Aims to Standardize Digital Pathology Workflows

Digital pathology is expanding rapidly as laboratories adopt whole-slide imaging and computational tools to meet growing diagnostic and biomarker-testing demand. However, fragmented software infrastructure... Read more

Genetic Testing Program Expands Detection of Alpha-1 Antitrypsin Deficiency

Alpha-1 Antitrypsin Deficiency (AATD) is a progressive genetic condition, the leading known genetic risk factor for chronic obstructive pulmonary disease (COPD), and a cause of liver disease in both children... Read more

Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer

Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more

Diazyme Laboratories Acquires Carolina Liquid Chemistries

Diazyme Laboratories, Inc. (Poway, CA, USA), a diagnostics company developing enzyme and immunoassay-based test reagents, has acquired the business of Carolina Liquid Chemistries Corporation (CLC, Greensboro,... Read more